What is happening to Aurobindo Pharma?

Aurobindo Pharma shares up 1.52% as Nifty gains The stock quoted a 52-week high price of Rs 1012.9 and low of Rs 503.4.

Why did Auropharma share price fall?

Shares of Hyderabad-based drugmaker Aurobindo Pharma fell as much as 4.5 per cent to hit an intraday low of Rs 685.85 after it received a warning letter from the US drug regulator – US Food and Drug Administration (USFDA) for its Hyderabad-based Unit I, an active pharmaceutical ingredient (API) manufacturing facility.

Is Aurobindo Pharma Debt Free?

What Is Aurobindo Pharma’s Debt? The image below, which you can click on for greater detail, shows that Aurobindo Pharma had debt of ₹43.9b at the end of September 2021, a reduction from ₹49.9b over a year. However, its balance sheet shows it holds ₹45.0b in cash, so it actually has ₹1.08b net cash.

Is Auro Pharma a good stock to buy?

It remains positive on Aurobindo’s long-term outlook considering its strong US pipeline with the possibility to launch more than 20 products every year, potential unlocking of injectable business, significant balance sheet improvement and investments in new segments for future growth (domestic formulation, biosimilars.

Is Aurobindo Pharma a good buy now?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Aurobindo Pharma Ltd is a good quality company. 2.

Is Aurobindo Pharma good buy?

Who is owner of Aurobindo Pharma?

Aurobindo Pharma

Type	Public
Founders	V. Ramprasad Reddy K. Nityananda Reddy
Headquarters	Hyderabad, Telangana, India
Products	Pharmaceuticals generic drugs over-the-counter drugs vaccines diagnostics contact lenses animal health
Revenue	₹23,290 crore (US$3.1 billion) (2020)

Will Auropharma go up?

Based on our forecasts, a long-term increase is expected, the “AUROPHARMA” stock price prognosis for 2027-06-18 is 695.648 INR. With a 5-year investment, the revenue is expected to be around +33.39%. Your current $100 investment may be up to $133.39 in 2027.

Is auropharma selling in NSE?

Considering last week candle, NSE:AUROPHARMA has already given confirmation of further sign of selling . Price has created harmonic Shark pattern with PRZ level 0.886 and 1.13 with price 651.70 and 548.75 respectively. As we have witnessed of bounce from 0.886 level but not sustained above 200 MA. Two things are possible here : 1.

Is Aurobindo Pharma a make or break stock?

Aurobindo Pharma – The stock has been an underperformer since May 2021 – Was the recent breakdown below 680 just a shakeout of weak hands or would it get resisted again? – We are soon to find out… The stock is near make or break zone.

Is auropharma making HH&HL?

Now Auropharma was in a downtrend/correction phase for some time and now has reached a strong Demand Zone (Daily, Weekly, Monthly) and took a good >10% bounced of it and is making HH & HL in smaller timeframes. Now… Very very simple logic chart is self-explanatory.

Is auropharma on the positive track?

#AUROPHARM Looks now the stock is now on the positive track. watch out of strong resistance @ 737. for now in watchlist. Auropharma made an inverse head & shoulder on daily charts. Could b bought with sloss 665 & tgt 818 Buy Auro bharma at current level 680. If its not break down current level this have chance to move up.